168 related articles for article (PubMed ID: 9364887)
21. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
[TBL] [Abstract][Full Text] [Related]
22. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
23. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
[TBL] [Abstract][Full Text] [Related]
25. The risks and benefits of clozapine versus chlorpromazine.
Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
[TBL] [Abstract][Full Text] [Related]
26. [Maintenance therapy in schizophrenia using clozapine].
Korínková V; Novotný V
Cesk Psychiatr; 1991 Apr; 87(2):92-6. PubMed ID: 1913953
[TBL] [Abstract][Full Text] [Related]
27. Predictors of clozapine response in schizophrenia.
Pickar D; Owen RR; Litman RE; Hsiao JK; Su TP
J Clin Psychiatry; 1994 Sep; 55 Suppl B():129-32. PubMed ID: 7525541
[TBL] [Abstract][Full Text] [Related]
28. Outcome of clozapine therapy for elderly patients with refractory primary psychosis.
Sajatovic M; Jaskiw G; Konicki PE; Jurjus G; Kwon K; Ramirez LF
Int J Geriatr Psychiatry; 1997 May; 12(5):553-8. PubMed ID: 9193964
[TBL] [Abstract][Full Text] [Related]
29. [Clinical experience with clozapine in 55 cases of treatment-resistant schizophrenia].
Enomoto T; Ito T; Sekine K; Yasui R; Ashizawa Y; Uju Y; Hayakawa T; Tsukada K
Seishin Shinkeigaku Zasshi; 2013; 115(9):953-66. PubMed ID: 24228473
[TBL] [Abstract][Full Text] [Related]
30. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
[TBL] [Abstract][Full Text] [Related]
31. Nursing evaluation of the use of clozapine: an interim progress report.
Quinn C
Aust N Z J Ment Health Nurs; 1995 Mar; 4(1):42-7. PubMed ID: 9086954
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
[TBL] [Abstract][Full Text] [Related]
33. [A critical study of conditions for prescription and evaluation criteria of neuroleptic treatment in resistant schizophrenia].
Petit M; Dollfus S
Encephale; 1992 Sep; 18 Spec No 3():447-51. PubMed ID: 1364078
[TBL] [Abstract][Full Text] [Related]
34. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
[TBL] [Abstract][Full Text] [Related]
35. [Clinical follow-up -- EEG -- serum determinations: therapeutic experience with clozapine].
Gekiere F; Dessalles MC; Poisson N; Maitre L
Encephale; 1996 Dec; 22 Spec No 6():16-23. PubMed ID: 9102314
[TBL] [Abstract][Full Text] [Related]
36. An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels.
Ng CH; Chong SA; Lambert T; Fan A; Hackett LP; Mahendran R; Subramaniam M; Schweitzer I
Int Clin Psychopharmacol; 2005 May; 20(3):163-8. PubMed ID: 15812267
[TBL] [Abstract][Full Text] [Related]
37. [Clinical efficacy of leponex according to the findings of an international study].
Panteleeva GN; Tsutsul'kovskaia MIa; Beliaev BS; Cheshkova E; Pavlovskiĭ P
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):393-401. PubMed ID: 6144219
[TBL] [Abstract][Full Text] [Related]
38. [Clozapine (Leponex) in France].
Péré JJ; Chaumet-Riffaud PD; Bourdeix I; Bourdain M
Encephale; 1992 Sep; 18 Spec No 3():427-32. PubMed ID: 1339758
[TBL] [Abstract][Full Text] [Related]
39. [Treatment-resistant schizophrenia].
Yahyaten OB
Rev Med Brux; 2014; 35(3):169-73. PubMed ID: 25102584
[TBL] [Abstract][Full Text] [Related]
40. An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.
Turetz M; Mozes T; Toren P; Chernauzan N; Yoran-Hegesh R; Mester R; Wittenberg N; Tyano S; Weizman A
Br J Psychiatry; 1997 Jun; 170():507-10. PubMed ID: 9330014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
